• Fund Type: Open-End Fund
  • Objective: Market Neutral
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Biotechnology Fund

+ Add to Watchlist

RYOIX:US

77.42 USD 0.44 0.57%

As of 09:29:30 ET on 09/17/2014.

Snapshot for Rydex Series - Biotechnology Fund (RYOIX)

Year To Date: +20.90% 3-Month: +8.83% 3-Year: +38.85% 52-Week Range: 56.98 - 79.84
1-Month: +2.25% 1-Year: +24.60% 5-Year: +24.59% Beta vs SPX: 1.09

Mutual Fund Chart for RYOIX

No chart data available.
  • RYOIX:US 77.42
  • 1M
  • 1Y
Interactive RYOIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYOIX

Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.

Inception Date: 04-01-1998 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / MIKE DELLAPA
Web Site: www.guggenheiminvestments.com

Fundamentals for RYOIX

NAV (on 2014-09-17) 77.42
Assets (M) (on 2014-09-17) 454.48
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYOIX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for RYOIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.36

Top Fund Holdings for RYOIX

Filing Date: 08/31/2014
Name Position Value % of Total
Gilead Sciences Inc 372,792 40,104,963 8.481%
Amgen Inc 217,954 30,378,429 6.424%
Celgene Corp 270,121 25,666,897 5.428%
Biogen Idec Inc 74,701 25,625,431 5.419%
Regeneron Pharmaceuticals Inc 48,314 16,935,023 3.581%
Puma Biotechnology Inc 60,551 15,774,141 3.336%
Alexion Pharmaceuticals Inc 93,176 15,773,765 3.336%
Vertex Pharmaceuticals Inc 153,112 14,326,690 3.030%
Illumina Inc 73,796 13,236,051 2.799%
Pharmacyclics Inc 76,000 9,453,640 1.999%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil